Literature DB >> 23490051

Dynamic range of Nef functions in chronic HIV-1 infection.

Philip Mwimanzi1, Tristan J Markle, Yoko Ogata, Eric Martin, Michiyo Tokunaga, Macdonald Mahiti, Xiaomei T Kuang, Bruce D Walker, Mark A Brockman, Zabrina L Brumme, Takamasa Ueno.   

Abstract

HIV-1 Nef is required for efficient viral replication and pathogenesis. However, the extent to which Nef's functions are maintained in natural sequences during chronic infection, and their clinical relevance, remains incompletely characterized. Relative to a control Nef from HIV-1 strain SF2, HLA class I and CD4 down-regulation activities of 46 plasma RNA Nef sequences derived from unique chronic infected individuals were generally high and displayed narrow dynamic ranges, whereas Nef-mediated virion infectivity, PBMC replication and CD74 up-regulation exhibited broader dynamic ranges. 80% of patient-derived Nefs were active for at least three functions examined. Functional co-dependencies were identified, including positive correlations between CD4 down-regulation and virion infectivity, replication, and CD74 up-regulation, and between CD74 up-regulation and PBMC replication. Nef-mediated virion infectivity inversely correlated with patient CD4(±) T-cell count. Strong functional co-dependencies and the polyfunctional nature of patient-derived Nef sequences suggest a phenotypic requirement to maintain multiple Nef functions during chronic infection.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23490051     DOI: 10.1016/j.virol.2013.02.005

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

1.  Differential Ability of Primary HIV-1 Nef Isolates To Downregulate HIV-1 Entry Receptors.

Authors:  Mako Toyoda; Yoko Ogata; Macdonald Mahiti; Yosuke Maeda; Xiaomei T Kuang; Toshiyuki Miura; Heiko Jessen; Bruce D Walker; Mark A Brockman; Zabrina L Brumme; Takamasa Ueno
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

2.  Nef-mediated inhibition of NFAT following TCR stimulation differs between HIV-1 subtypes.

Authors:  Lisa Naidoo; Zinhle Mzobe; Steven W Jin; Erasha Rajkoomar; Tarylee Reddy; Mark A Brockman; Zabrina L Brumme; Thumbi Ndung'u; Jaclyn K Mann
Journal:  Virology       Date:  2019-02-21       Impact factor: 3.616

3.  Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular Cytotoxicity.

Authors:  Nirmin Alsahafi; Shilei Ding; Jonathan Richard; Tristan Markle; Nathalie Brassard; Bruce Walker; George K Lewis; Daniel E Kaufmann; Mark A Brockman; Andrés Finzi
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

4.  Resistance of Major Histocompatibility Complex Class B (MHC-B) to Nef-Mediated Downregulation Relative to that of MHC-A Is Conserved among Primate Lentiviruses and Influences Antiviral T Cell Responses in HIV-1-Infected Individuals.

Authors:  Francis Mwimanzi; Mako Toyoda; Macdonald Mahiti; Jaclyn K Mann; Jeffrey N Martin; David Bangsberg; Mark A Brockman; Philip Goulder; Frank Kirchhoff; Zabrina L Brumme; Thumbi Ndung'u; Takamasa Ueno
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

5.  HIV Subtype and Nef-Mediated Immune Evasion Function Correlate with Viral Reservoir Size in Early-Treated Individuals.

Authors:  Fredrick H Omondi; Sandali Chandrarathna; Shariq Mujib; Chanson J Brumme; Steven W Jin; Hanwei Sudderuddin; Rachel L Miller; Asa Rahimi; Oliver Laeyendecker; Phil Bonner; Feng Yun Yue; Erika Benko; Colin M Kovacs; Mark A Brockman; Mario Ostrowski; Zabrina L Brumme
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

6.  Impaired Nef function is associated with early control of HIV-1 viremia.

Authors:  Xiaomei T Kuang; Xiaoguang Li; Gursev Anmole; Philip Mwimanzi; Aniqa Shahid; Anh Q Le; Louise Chong; Hua Qian; Toshiyuki Miura; Tristan Markle; Bemuluyigza Baraki; Elizabeth Connick; Eric S Daar; Heiko Jessen; Anthony D Kelleher; Susan Little; Martin Markowitz; Florencia Pereyra; Eric S Rosenberg; Bruce D Walker; Takamasa Ueno; Zabrina L Brumme; Mark A Brockman
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

7.  An Amino Acid Polymorphism within the HIV-1 Nef Dileucine Motif Functionally Uncouples Cell Surface CD4 and SERINC5 Downregulation.

Authors:  Mitchell J Mumby; Aaron L Johnson; Steven M Trothen; Cassandra R Edgar; Richard Gibson; Peter B Stathopulos; Eric J Arts; Jimmy D Dikeakos
Journal:  J Virol       Date:  2021-07-26       Impact factor: 5.103

8.  No evidence for selection of HIV-1 with enhanced gag-protease or Nef function among breakthrough infections in the CAPRISA 004 tenofovir microbicide trial.

Authors:  Denis R Chopera; Jaclyn K Mann; Philip Mwimanzi; Saleha Omarjee; Xiaomei T Kuang; Nonkululeko Ndabambi; Sarah Goodier; Eric Martin; Vivek Naranbhai; Salim Abdool Karim; Quarraisha Abdool Karim; Zabrina L Brumme; Thumbi Ndung'u; Carolyn Williamson; Mark A Brockman
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

9.  Genotypic and functional impact of HIV-1 adaptation to its host population during the North American epidemic.

Authors:  Laura A Cotton; Xiaomei T Kuang; Anh Q Le; Jonathan M Carlson; Benjamin Chan; Denis R Chopera; Chanson J Brumme; Tristan J Markle; Eric Martin; Aniqa Shahid; Gursev Anmole; Philip Mwimanzi; Pauline Nassab; Kali A Penney; Manal A Rahman; M-J Milloy; Martin T Schechter; Martin Markowitz; Mary Carrington; Bruce D Walker; Theresa Wagner; Susan Buchbinder; Jonathan Fuchs; Beryl Koblin; Kenneth H Mayer; P Richard Harrigan; Mark A Brockman; Art F Y Poon; Zabrina L Brumme
Journal:  PLoS Genet       Date:  2014-04-24       Impact factor: 5.917

10.  Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes.

Authors:  Jaclyn K Mann; Helen Byakwaga; Xiaomei T Kuang; Anh Q Le; Chanson J Brumme; Philip Mwimanzi; Saleha Omarjee; Eric Martin; Guinevere Q Lee; Bemuluyigza Baraki; Ryan Danroth; Rosemary McCloskey; Conrad Muzoora; David R Bangsberg; Peter W Hunt; Philip J R Goulder; Bruce D Walker; P Richard Harrigan; Jeff N Martin; Thumbi Ndung'u; Mark A Brockman; Zabrina L Brumme
Journal:  Retrovirology       Date:  2013-09-16       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.